Though tobacco usage has decreased in some countries, it still remains a significant public health concern for various populations
Fortunately, we do have medications that can clearly help people control and reduce alcohol use, including naltrexone, topiramate, acamprosate, and now the newest group, the GLP-1 agonists (Ozempic, Mounjaro, Wegovy, etc.), which some clinics are using as baseline treatment
In addition, the number of regular smokers in the Czech Republic has declined over the past years, with medical professionals crediting the ban for helping some quit
"JTI Korea pays Instagram users for cigarette postings"
Secondhand smoke exposure, for example, contributes to health problems in non-smokers, leading to increased healthcare utilization and costs